theaflavic acid

Also Known As:

3,4,5-Trihydroxy-6-oxo-1-(3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl)-6H-benzo(7)annulene-8-carboxylic acid; 6H-Benzocycloheptene-8-carboxylic acid, 1-(3,4-dihydro-3,5,7-trihydroxy-2H-1-benzopyran-2-yl)-3,4,5-trihydroxy-6-oxo-

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - theaflavic acid: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - theaflavic acid: 1

Experts

1.	Duan, Yinyin: 1 article (01/2020)
2.	Li, Yafeng: 1 article (01/2020)
3.	Li, Yan: 1 article (01/2020)
4.	Shi, Jing: 1 article (01/2020)
5.	Sun, Xinting: 1 article (01/2020)
6.	Yao, Huankai: 1 article (01/2020)

Related Diseases

1.	Ischemic Stroke 01/01/2020 - "In our continual search for bioactive natural products for the treatment of ischemic stroke, we have evaluated the protective effects of theaflavic acid (TFA) from black tea using PC12 cells injured by oxygen and glucose deprivation/restoration (OGD/R), and investigated the possible mechanisms. "

Related Drugs and Biologics

1.	Tea
2.	Oxygen (Dioxygen)
3.	Glucose (Dextrose)